- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
By 
Kyle Brasseur2022-10-18T19:39:00
An audit partner at accounting firm Spielman Koenigsberg & Parker (SKP) agreed to pay a record $150,000 fine handed down by the Public Company Accounting Oversight Board (PCAOB) for misleading its investigators over the course of multiple inspections.
The alleged actions of Jonathan Taylor also earned SKP a fine of $150,000 and led to the PCAOB revoking the firm’s registration for at least five years. SKP was further censured for failing to establish and implement adequate quality control policies and procedures, according to the regulator.
Taylor agreed to be censured and permanently barred from association with a registered public accounting firm as part of his settlement. His financial penalty total is the highest the regulator has assessed against an individual.
THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.
News and analysis for the well-informed compliance or audit exec. Select an option and click continue.
Annual Membership $499 Value offer
Full price one year membership with auto-renewal.
Membership $599
One-year only, no auto-renewal.
The Public Company Accounting Oversight Board announced Robert Rice would succeed Mark Adler as head of enforcement and investigations.
The Public Company Accounting Oversight Board announced several notable enforcement actions last week, including sanctions against six firms for allegedly violating agency reporting requirements.
The Public Company Accounting Oversight Board penalized four audit firms for failing to disclose who led specific audits for their firms and whether any other firms were involved in those audits.
German petrochemical parts supplier Aiotec agreed to pay $14.5 million to settle allegations that it engaged in a four-year conspiracy to dismantle and ship a plastics manufacturing plant owned by a U.S. company to Iran, in violation of U.S. sanctions.
Kiromic BioPharma will pay no fine to the Securities and Exchange Commission after self-reporting that it failed to disclose material information about two cancer drugs to investors.
The U.K. Financial Conduct Authority fined the London branch of Australian-based Macquarie Bank Limited more than 13 million pounds (U.S. $16.3 million) for “serious control failures” that allowed a trader to conceal hundreds of fictitious trades over a 20-month period.
